InvestorsHub Logo

Investintin

02/22/18 8:51 AM

#284391 RE: NASDAQ2020 #284390

Which one will be first ?



I would go with: another disappointing CRL and more lengthy excuses as to why the ANDAs haven't been approved yet... followed by hardcore fans claiming that it is a conspiracy by FDA and the whole world vs poor Elite

Or another split... either ;)

namtae

02/22/18 9:00 AM

#284392 RE: NASDAQ2020 #284390

I can tell you which ones HAVENT been first

1.) SequestOx ® First ever Immediate Release ADF labeled opiod with ORAL AD Labeling
2.) First ever generic ER 2 bead ADF labeled Oxycodone ELI-201
3.) First ever generic Troxyca® waiting comparator product launch
4.) A $50 million dollar ANDA
5.) Approval/Launch of First ever Abuse Deterrent (physical barrier) generic (reformulated OxyContin® ) filed 09-20/2017
6.) File Huge Blockbuster Undisclosed NDA
7.) Launch first four SunGen generics (2016) ($3 Billion combined markets) The two SunGen deals have a combined market worth $6 billion
8.) Buyout/Acquisition
9.)BP Partnership for entire ADF line 10.)Uplisting to NASDAQ
exchange 2018-19
11.) First ever ER opiod with out food restrictions
12.) Complete PH III trials for the first ever 24 hour
13.) Generic of Reformulated Opana ® ER
14.) First ADF opiod for Chinese Pain Market --PuraCap/Humanwell
15.) Canadian Approval of SequestOx ® - patents in place
16.) FDA accepts citizen petition urging the FDA to phase out oral prescription opioid analgesics that lack abuse-deterrent properties
17.) First ever generic Embeda®
18.) Launch additional 2017 SunGen generics brings the market to $6 billion
19.) Chinese approval of SequestOx ® CEO met with Chinese Feb 2017
20.) European approval of AD oxycodone/opiod - patents in place